Sitagliptin Chemical Structure (Janumet 01)
Janumet Tablet, Film Coated
Product Images NDC 0006-0575
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Janumet (NDC 0006-0575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Metformin Hydrochloride Chemical Structure (Janumet 02)
Figure 1 (Janumet 03)
Figure 2 (Janumet 04)
Principal Display Panel (50 mg/500 mg Tablet Bottle Label)
Janumet is a medication available in tablet form with NDC 0006-0575-61 code and is prescribed through Rxonly. Each 50mg/500mg tablet contains 64.25 g aglpti phosphate (equivalent 50 m staglptn) and 00 g metformin hycrochioride. The medication guide should be provided to each patient. Storage should be at room temperature not exceeding 20.25°C (68.77°F). The standard dosage information is available in the package inset. The GTIN is 00300060575617.*
Principal Display Panel (50 mg/1,000 mg Tablet Bottle Label)
Janumet is a medication that comes in tablet form with the NDC code 0006-0577-61. It contains a combination of sitagliptin and metformin HCl with a strength of 50mg/1000mg. This medication should be given with a dispensing of a Medication Guide for each patient. The tablet contains 6425mg of sitagliptin phosphate and 1000mg of metformin hydrochloride. The standard dosage instructions can be found in the package insert. The medication should be stored at 20-25°C (68.77°F) with excursions permitted at 15-30°C.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
